DISSEMINATED STRONGYLOIDIASIS - AN UNHERALDED RISK OF CORTICOSTEROID-THERAPY

被引：18

作者：

KASLOW, JE ^{[1
]}

NOVEY, HS ^{[1
]}

ZUCH, RH ^{[1
]}

SPEAR, GS ^{[1
]}

机构：

[1] UNIV CALIF IRVINE,DEPT PATHOL,ORANGE,CA 92613

来源：

关键词：

D O I：

10.1016/S0091-6749(05)80135-6

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：138 / 138

页数：1

共 7 条

[1] FATAL STRONGYLOIDIASIS FOLLOWING CORTICOSTEROID THERAPY [J].

CIVANTOS, F ;

ROBINSON, MJ .

AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1969, 14 (09) :643-&

GILL, GV ;

BELL, DR .

[3]

IGRASIEGMAN Y, 1981, REV INFECT DIS, V3, P397

[4] CLINICAL STUDIES IN HUMAN STRONGYLOIDIASIS .1. SEMEIOLOGY [J].

JONES, CA .

[5]

MANSONBAR PEL, 1982, MANSONS TROPICAL DIS, P194

[6] BIOLOGY AND IMMUNOLOGY OF HUMAN STRONGYLOIDIASIS [J].

NEVA, FA .

SCOWDEN, EB ;

SCHAFFNER, W ;

STONE, WJ .